Evidence map›Paper›PMID 37215598›Full record

ArticleFrontiers in pediatrics2023

Assessing the burden of bronchiolitis and lower respiratory tract infections in children ≤24 months of age in Italy, 2012-2019.

Elisa Barbieri, Sara Cavagnis, Antonio Scamarcia, Luigi Cantarutti, Lorenzo Bertizzolo, Mathieu Bangert, Salvatore Parisi, Anna Cantarutti, Eugenio Baraldi, Carlo Giaquinto and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Sex- and gender-based medicine in pediatric nutrition.Italian journal of pediatrics · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Observational
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Elisa BarbieriDivision of Paediatric Infectious Diseases, Department for Women's and Children's Health, University of Padua, Padua, Italy.
Sara CavagnisSocieta' Servizi Telematici - Pedianet, Padua, Italy.
Antonio ScamarciaSocieta' Servizi Telematici - Pedianet, Padua, Italy.
Luigi CantaruttiSocieta' Servizi Telematici - Pedianet, Padua, Italy.
Lorenzo BertizzoloSanofi Vaccines, Lyon, France.
Mathieu BangertSanofi Vaccines, Lyon, France.
Salvatore ParisiSanofi Vaccines, Milan, Italy.
Anna CantaruttiUnit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Eugenio BaraldiNeonatal Intensive Care Unit, Department of Women's and Children's Health, University of Padua, Padua, Italy.
Carlo GiaquintoDivision of Paediatric Infectious Diseases, Department for Women's and Children's Health, University of Padua, Padua, Italy.
Vincenzo BaldoDepartment of Cardiac Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
University of Padua · ITInformatica Tecnologie e Servizi (Italy) · ITSanofi (France) · FRSanofi (Italy) · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bronchiolitis is the most common lower respiratory tract infection (LRTI) in children and is mainly caused by the Respiratory Syncytial Virus (RSV). Bronchiolitis presents seasonally and lasts about five months, usually between October to March, with peaks of hospitalizations between December and February, in the Northern Hemisphere. The burden of bronchiolitis and RSV in primary care is not well understood. Materials and methods: This retrospective analysis used data from Pedianet, a comprehensive paediatric primary care database of 161 family paediatricians in Italy. We evaluated the incidence rates (IR) of all-cause bronchiolitis (ICD9-CM codes 466.1, 466.11 or 466.19), all-cause LRTIs, RSV-bronchiolitis and RSV-LRTIs in children from 0 to 24 months of age, between January 2012 to December 2019. The role of prematurity (<37 weeks of gestational age) as a bronchiolitis risk factor was evaluated and expressed as odds ratio. Results: Of the 108,960 children included in the study cohort, 7,956 episodes of bronchiolitis and 37,827 episodes of LRTIs were recorded for an IR of 47 and 221 × 1,000 person-years, respectively. IRs did not vary significantly throughout the eight years of RSV seasons considered, showing a seasonality usually lasting five months, between October and March, while the peak of incidence was between December and February. Bronchiolitis and LRTI IRs were higher during the RSV season, between October and March, regardless of the month of birth, with bronchiolitis IR being higher in children aged ≤12 months. Only 2.3% of bronchiolitis and LRTI were coded as RSV-related. Prematurity and comorbidity increased the risk of bronchiolitis; however, 92% of cases happened in children born at term, and 97% happened in children with no comorbidities or otherwise healthy. Conclusions: Our results confirm that all children aged ≤24 months are at risk of bronchiolitis and LRTI during the RSV season, regardless of the month of birth, gestational age or underlying health conditions. The IRs of bronchiolitis and LRTI RSV-related are underestimated due to the poor outpatient epidemiological and virological surveillance. Strengthening the surveillance system at the paediatric outpatient level, as well as at the inpatient level, is needed to unveil the actual burden of RSV-bronchiolitis and RSV-LRTI, as well as to evaluate the effectiveness of new preventive strategies for anti-RSV.

Indexed as

bronchiolitischildrenepidemiologyItalylower respiratory tract infection (LRTI)respiratory syncytial virus

Identifiers

PMID37215598
PMCPMC10196108
OpenAlexW4377563839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.